Biotech company Mineralys Therapeutics shares fell 2.3% after the company set its expanded share offering price of $250 million at $25.50 per share. The release is expected to be completed on September 4, 2025. The funds raised will be used to support the company's growth plans.

Zhitongcaijing · 09/03/2025 14:41
Biotech company Mineralys Therapeutics shares fell 2.3% after the company set its expanded share offering price of $250 million at $25.50 per share. The release is expected to be completed on September 4, 2025. The funds raised will be used to support the company's growth plans.